The "Immunotherapy Drugs: Global Markets" report has been added to ResearchAndMarkets.com's offering.

The global immunotherapy drugs market is expected to grow from $260.7 billion in 2025 and is projected to reach $467.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% during the forecast period of 2025 to 2030.

Despite challenges, the immunotherapy field is rapidly evolving, with researchers developing more effective approaches such as personalized cancer vaccines and oncolytic viruses. Immunotherapy has demonstrated its potential for multiple diseases, particularly cancer, with ongoing research likely to yield even more effective and personalized therapies.

The current report provides detailed information on immunotherapy drugs. It analyzes the market trends with data from 2024, estimates for 2025 and projections of compound annual growth rates (CAGRs) from 2025 through 2030, including regional markets for immunotherapy drugs. This report highlights the current and future market potential and provides a detailed discussion on the competitive environment. The report will also cover regulatory scenarios, drivers, restraints and opportunities. Additionally, it covers market share data for key companies.

The report aims to:

• Analyze types of immunotherapies.
• Analyze global market size and segmentation.
• Understand market constraints and drivers.
• Provide detailed market forecasts through 2030.
• Assess market shares, competitiveness and industry structure.
• Identify potential long-term impacts on the immunotherapy drug market.

The report includes:

• 88 data tables and 57 additional tables
• An overview of the global market for immunotherapy drugs
• In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, and forecasts for 2030, including projections of CAGRs through 2030
• Evaluation of the current market size and revenue growth prospects specific to the immunotherapy drugs, accompanied by a market share analysis by therapy type, application and region
• Description of immunotherapy and combination immunotherapy, and discussion of how it targets cell-mediated adaptive immunity
• Details of checkpoint inhibitors, monoclonal antibodies, interleukins and interferons; and coverage of innovative strategies and new targeted approaches for immunotherapy
• Analysis of the current and future demands in the global immunotherapy drugs, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
• Analysis of drivers, challenges and opportunities affecting the market's growth
• Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
• Market share analysis of the key companies in the immunotherapy drugs, along with their research priorities, product portfolios, global rankings and the competitive landscape
• Profiles of major companies in industry, including: F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, and Sanofi

Companies Featured

• Abbvie Inc.
• Amgen Inc.
• Astrazeneca
• Bristol-Myers Squibb Co.
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences Inc.
• Gsk PLC.
• Johnson & Johnson Services Inc.
• Lilly
• Merck & Co.Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.

Key Attributes:

Key Topics Covered:

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Overview
• Macroeconomic Factor Analysis
• Impact of U.S. Tariffs on the Pharmaceutical Industry
• Healthcare Expenditure
• Impact of GDP on the Pharma Sector
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential for New Entrants
• Threat of Substitutes
• Competitiveness in the Industry

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Increasing Incidence of Chronic Diseases
• Increasing R&D Spending by Market Players
• Rise in Government Funding and Pharmaceutical R&D Spending
• Market Restraints
• High Cost of Immunotherapy Drugs
• Rising Generic Competition
• Lack of Skilled Professionals
• Market Opportunities
• Technological Advances in Immunotherapy
• Potential in Immunotherapy

Chapter 4 Regulatory Landscape

• Overview
• U.S.
• Europe
• Asia-Pacific

Chapter 5 Emerging Technologies and Pipeline Analysis

• Overview
• AI and ML
• Emergent Biomarkers
• Genome Editing and CRISPR
• Pipeline Analysis
• Key Takeaways
• Patent Analysis
• Key Takeaways

Chapter 6 Market Segment Analysis

• Segmentation Breakdown
• Global Market for Immunotherapy Drugs, by Therapy Type
• Key Takeaways
• Monoclonal Antibodies
• Checkpoint Inhibitors
• Cytokines
• Others
• Global Immunotherapy Drug Market, by Application
• Key Takeaways
• Cancer
• Autoimmune Diseases
• Chronic Inflammatory Respiratory Condition
• Geographic Breakdown
• Global Market for Immunotherapy Drugs by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Landscape
• Company Share Analysis

Chapter 8 Sustainability in Immunotherapy Drugs Market: An ESG Perspective

• Introduction to ESG
• Sustainability in the Immunotherapy Drug Market
• ESG Perspective
• Environmental Impact
• Social Impact
• Governance Impact
• ESG Risk Ratings
• Conclusion

For more information about this report visit https://www.researchandmarkets.com/r/qypknq

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260102445663/en/